Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1891811 | 0.93 | SLC33A1 (0.54) | SLC33A1 | |
| SCHEMBL4306427 | 0.90 | SLC33A1 (0.50) | SLC33A1PPARG | |
| SCHEMBL2842927 | 0.89 | SLC33A1 (0.49) | SLC33A1 | |
| SCHEMBL4306392 | 0.88 | SLC33A1 (0.45) | SLC33A1PPARG | |
| SCHEMBL4304253 | 0.87 | SLC33A1 (0.44) | SLC33A1PPARG | |
| SCHEMBL13626581 | 0.86 | SLC33A1 (0.57) | SLC33A1PPARG | |
| SCHEMBL1894778 | 0.86 | SLC33A1 (0.54) | SLC33A1 | |
| SCHEMBL1888050 | 0.86 | SLC33A1 (0.54) | SLC33A1 | |
| SCHEMBL1891275 | 0.86 | SLC33A1 (0.54) | SLC33A1 | |
| SCHEMBL4304292 | 0.86 | SLC33A1 (0.45) | SLC33A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100056526-A1 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056526-A1 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF | CYP11B2, CYP11B1, NR3C2 | SLC33A1 1772/4885PPARG 1212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.